TCG Crossover GP II, LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | TCG Crossover GP II, LLC | 4,100,029 9.990% | 1,397,872 (+51.73%) | Filing |
| 2023-10-16 4:37 pm Purchase | 2023-10-04 | 13G | VISTAGEN THERAPEUTICS INC VTGN | TCG Crossover GP II, LLC | 2,702,157 9.900% | 2,702,157 (New Position) | Filing |